Golden
Autolus

Autolus

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

All edits

Edits on 25 Apr 2019
Golden AI
Golden AI edited on 25 Apr 2019 12:52 am
Edits made to:
Infobox (+2 properties)

Infobox

Edits on 30 Mar 2019
Dawson Sewell
Dawson Sewell edited on 30 Mar 2019 6:20 pm
Edits made to:
Infobox (+4 properties)
Edits on 15 Mar 2019
Dawson Sewell
Dawson Sewell edited on 15 Mar 2019 6:42 pm
Edits made to:
Infobox (+11 properties)
Article (+48/-48 characters)
Further reading (+12 cells) (+775 characters)
Documentaries, videos and podcasts (+3 cells) (+101 characters)
Categories (+2 topics)
Related Topics (+2/-2 topics)

Article

Autolus develops and commercializes engineered T-cell immunotherapyimmunotherapy products to treat cancer. Autolus supplies engineering chimeric antigen receptors (CAR) T-cell products that kill malignant cells and protect from malignancy in the long-term. The company provides T-cell products for hematological and solid tumors.

...

T-cells normally detect and eliminate abnormal or cancerous cells in the body but sometimes cells escape detection and develop into tumors. Autolus programs T-cells to recogniserecognize and destroy tumour cells by transferring a gene into T-cells so they express Chimeric Antigen ReceptorsChimeric Antigen Receptors (CARs) or T-cell receptors (TCRs) that recognize targets on the surface of malignant cells. For their process Autolus uses their own proprietary viral vector and semi-automated cell manufacturing processes. 

Further reading

Title
Author
Link
Type

Autolus Therapeutics Announces Update on its Novel CAR T Cell Program for Peripheral T Cell Lymphoma (PTCL)

Autolus Therapeutics plc

Web

Biotech to create 170 jobs, invest $28M in new Rockville HQ

Katie Arcieri

Web

Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies

Vineti

Web

Documentaries, videos and podcasts

Title
Date
Link

Cell Therapy Commercialization in Oncology

January 8, 2019

Infobox

Categories

Related Topics

Edits on 10 Jan 2019
Meredith Hanel
Meredith Hanel edited on 10 Jan 2019 5:47 pm
Edits made to:
Description (+224 characters)
Article (+805 characters)
People (+10 cells) (+178 characters)
Related Topics (+2 topics)
Topic thumbnail

Autolus

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

Article

Autolus develops and commercializes engineered T-cell immunotherapy products to treat cancer. Autolus supplies engineering chimeric antigen receptors (CAR) T-cell products that kill malignant cells and protect from malignancy in the long-term. The company provides T-cell products for hematological and solid tumors.

...

T-cells normally detect and eliminate abnormal or cancerous cells in the body but sometimes cells escape detection and develop into tumors. Autolus programs T-cells to recognise and destroy tumour cells by transferring a gene into T-cells so they express Chimeric Antigen Receptors (CARs) or T-cell receptors (TCRs) that recognize targets on the surface of malignant cells. For their process Autolus uses their own proprietary viral vector and semi-automated cell manufacturing processes. 

People

Name
Role
Related Golden topics

Dr. Christian Martin Itin

Chairman, CEO



Dr. Jim Faulkner, PhD

Head of Manufacturing



Dr. Louise Holliday

Head of Intellectual Property



Dr. Martin Pulé

Founder, CSO



Mr. Christopher Vann

COO



Related Topics

Edits on 25 Jul 2018
Melanie Manipula
Melanie Manipula edited on 25 Jul 2018 12:16 am
Edits on 20 Apr 2018
Melanie Manipula
Melanie Manipula edited on 20 Apr 2018 11:38 pm
Edits made to:
Topic thumbnail

Autolus

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 20 Apr 2018 11:34 pm
Edits made to:
Description
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Autolus

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

No more activity to show.